Everyday activity strategies perceived by people with advanced cancer: a qualitative explorative study by Karen la Cour, Lisa Gregersen Oestergaard, Marc Sampedro Pilegaard

Subjects: Get full text

Feasibility of implementing a decision aid for advanced cancer patients in a comprehensive cancer centers' outpatient setting: Valuable lessons learned by K. Laryionava, R. Boekels, J. Schildmann, M. Wensing, U. Wedding, B. Surmann, K. Mehlis, C. Gebel, M. Cinci, K. Krug, E. C. Winkler

Subjects: “…advanced cancer…”
Get full text

Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors by Xinyue Han, Yingcui Chen, Hong Xie, Yuekai Zhang, Yu Cui, Yaping Guan, Weiwei Nie, Qi Xie, Jisheng Li, Baocheng Wang, Bicheng Zhang, Jun Wang

Subjects: Get full text

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer by Cecilia Olsson Ladjevardi, Marcus Skribek, Anthoula Koliadi, Viktoria Rydén, Ali Inan El-Naggar, Evangelos Digkas, Antonios Valachis, Gustav J. Ullenhag

Subjects: Get full text